Date: November 4th, 2026
Location: Convene One Boston Place, Boston, MA
The Tufts University Center for the Study of Drug Development will be convening an invitation-only executive roundtable on November 4, 2026, in Boston, MA. The roundtable will focus on how organizations are using AI to enhance and ultimately transform clinical development. We are reaching out to gauge interest among a select group of colleagues and industry leaders.
The roundtable will address questions including:
- What is the current state of implementation of AI-enabled clinical development solutions in biopharma?
- What characteristics typify projects and organizations that move successfully from pilot to implementation?
- What challenges are organizations facing as they attempt to implement AI-enabled solutions?
- How are leading organizations thinking about moving from automating existing workflows to implementing transformative processes?
Are organizations currently evaluating benefit-cost and ROI of AI-enabled solutions?
The session will be designed as an interactive discussion, bringing together perspectives on emerging evidence and the practical application of AI solutions across clinical development.
Register Now
View the agenda and register to participate. If you are unable to attend, please submit a colleague from your organization who may be able to attend.
Agenda
| 8:30 - 9am | Breakfast/ Check in |
| 9 – 9:30am | Introductions |
| 9:30 – 10am | Current State of AI Solutions Implementation |
| 10 – 11:15am | Preliminary Findings from the CSDD Study of AI Implementation |
| 11:15am – 12:00pm | Case Study/Panel Discussion |
| 12:00 – 1:00pm | Lunch |
| 1:00 – 2:30pm | Interactive Session: From Insight to Impact- Identifying Solutions Developing the Path Forward |
| 2:30 – 3pm | Conclusion: Future Outlook for AI in Clinical Development Next Steps and Closeout |